EMEA-002501-PIP01-18-M03
EMEA-002501-PIP01-18-M03
EMEA-002501-PIP01-18-M03
EMEA-001835-PIP01-15-M05
Opinion/decision on a Paediatric investigation plan (PIP): VeraSeal, human fibrinogen,human thrombin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0052/2021
EMEA-002934-PIP01-20
Opinion/decision on a Paediatric investigation plan (PIP): Lenvima, Lenvatinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0280/2022
Opinion/decision on a Paediatric investigation plan (PIP): Upstaza, Eladocagene exuparvovec, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0075/2023
Opinion/decision on a Paediatric investigation plan (PIP): Aflunov, Influenza virus surface antigens - A/turkey/Turkey/1/05 (H5N1), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0189/2020
EMEA-002475-PIP02-19-M02
EMEA-003330-PIP01-22
Opinion/decision on a Paediatric investigation plan (PIP): Palforzia, defatted powder of Arachis hypogaea L., semen (peanuts), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0103/2023